Literature DB >> 19699081

Cervical cancer screening policies and coverage in Europe.

Ahti Anttila1, Lawrence von Karsa, Auni Aasmaa, Muriel Fender, Julietta Patnick, Matejka Rebolj, Florian Nicula, Laszlo Vass, Zdravka Valerianova, Lydia Voti, Catherine Sauvaget, Guglielmo Ronco.   

Abstract

The aim of the study was to compare current policy, organisation and coverage of cervical cancer screening programmes in the European Union (EU) member states with European and other international recommendations. According to the questionnaire-based survey, there are large variations in cervical cancer screening policies and inadequacies in the key organisational elements of the programme such as registration and monitoring required for quality-assurance and fail-safe mechanisms. Based on data from available screening registers, coverage of the screening test taken within the population-based programme was below 80% in all programmes, ranging from 10% to 79%. The screening capacity is satisfactory in most EU member states, however, and there is even over-capacity in several countries. There are also countries which do not have an acceptable capacity yet. Control of proper capacity along with education, training and communication among women, medical professionals and authorities are required, accordingly. The study indicates that, despite substantial efforts, the recommendations of the Council of the EU on organised population-based screening for cervical cancer are not yet fulfilled. Decision-makers and health service providers should consider stronger measures or incentives in order to improve cervical cancer control in Europe.

Entities:  

Mesh:

Year:  2009        PMID: 19699081     DOI: 10.1016/j.ejca.2009.07.020

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  25 in total

1.  Pricing human papillomavirus vaccines: lessons from Italy.

Authors:  Livio Garattini; Katelijne van de Vooren; Alessandro Curto
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

Review 2.  Health-related quality of life as measured by the EQ-5D in the prevention, screening and management of cervical disease: A systematic review.

Authors:  A Ó Céilleachair; J F O'Mahony; M O'Connor; J O'Leary; C Normand; C Martin; L Sharp
Journal:  Qual Life Res       Date:  2017-06-26       Impact factor: 4.147

3.  Cervical cancer screening in the United States and the Netherlands: a tale of two countries.

Authors:  Dik Habbema; Inge M C M De Kok; Martin L Brown
Journal:  Milbank Q       Date:  2012-03       Impact factor: 4.911

4.  Recommendations on screening for cervical cancer.

Authors:  James Dickinson; Eva Tsakonas; Sarah Conner Gorber; Gabriela Lewin; Elizabeth Shaw; Harminder Singh; Michel Joffres; Richard Birtwhistle; Marcello Tonelli; Verna Mai; Meg McLachlin
Journal:  CMAJ       Date:  2013-01-07       Impact factor: 8.262

5.  Effect of pay-for-performance on cervical cancer screening participation in France.

Authors:  Panayotis Constantinou; Jonathan Sicsic; Carine Franc
Journal:  Int J Health Econ Manag       Date:  2016-12-22

Review 6.  Economic evaluation of human papilloma virus vaccination in the European Union: a critical review.

Authors:  Daniela Koleva; Paola De Compadri; Anna Padula; Livio Garattini
Journal:  Intern Emerg Med       Date:  2011-02-11       Impact factor: 3.397

7.  [Cervical cancer screening in Germany. Current status].

Authors:  V Schneider
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

8.  Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014.

Authors:  Xueting Li; Rongshou Zheng; Xuemei Li; Haibin Shan; Qi Wu; Yan Wang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2017-12       Impact factor: 5.087

9.  Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study.

Authors:  Matejka Rebolj; Theo Helmerhorst; Dik Habbema; Caspar Looman; Rob Boer; Joost van Rosmalen; Marjolein van Ballegooijen
Journal:  BMJ       Date:  2012-10-31

10.  Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx).

Authors:  Naz Chaudary; Melania Pintilie; Joerg Schwock; Neesha Dhani; Blaise Clarke; Michael Milosevic; Anthony Fyles; Richard P Hill
Journal:  Cancers (Basel)       Date:  2012-08-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.